Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size (Q36203360)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

author name string

David B Burr

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

publication date

1 March 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

published in

Current osteoporosis reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

page(s)

19-24

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

cites work

Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of early bone histomorphometric effects of parathormone and alendronate in osteoporotic women

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of osteoporosis with parathyroid peptide (hPTH 1–34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic biomechanical measurements of bone: a tutorial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Geometric structure of the femoral neck measured using dual-energy x-ray absorptiometry

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mid-femur geometry and biomechanical properties in 15- to 18-yr-old female athletes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations of hormone replacement therapy with bone structure and physical performance among postmenopausal women.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16036097

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11914-005-0023-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

PubMed publication ID

16036097

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16036097

retrieved

12 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36203360&oldid=2198330070"